AI assistant
Sending…
Marker Therapeutics, Inc. — Director's Dealing 2007
Jul 19, 2007
35150_dirs_2007-07-19_327751f6-8fec-4b4a-90d6-75902bf3098d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: TAPIMMUNE INC (TPIM)
CIK: 0001094038
Period of Report: 2007-06-08
Reporting Person: Jefferies Wilfred Arthur (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1443716 | Direct |
| Common Stock | 1108186 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option | $0.25 | 2017-06-08 | Common Stock (1000000) | Direct |
More from Marker Therapeutics, Inc.
Interim / Quarterly Report
2026
May 15
Proxy Solicitation & Information Statement
2026
Mar 20
Annual Report
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Annual Report
2026
Mar 18
Regulatory Filings
2026
Feb 9
Director's Dealing
2025
Nov 19
Director's Dealing
2025
Nov 19
Director's Dealing
2025
Nov 19
Major Shareholding Notification
2025
Nov 17